Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Steven R. Pliszka"'
Autor:
Amy S. Garrett, Steven R. Pliszka
Publikováno v:
Brazilian Journal of Psychiatry, Vol 42, Iss 1, Pp 1-2 (2020)
Externí odkaz:
https://doaj.org/article/977ca5b9dbb64813bf87239bc51d48e7
Autor:
Norberto J. DeSousa, Cassandra L. Uchida, Floyd R. Sallee, Paul Hammerness, Jeffrey H. Newcorn, Bev Incledon, Timothy E. Wilens, Stephen V. Faraone, Steven R. Pliszka
Publikováno v:
Journal of Attention Disorders
Objective: The Before School Functioning Questionnaire and Parent Rating of Evening and Morning Behavior–Revised assess early morning (BSFQ, PREMB-R AM subscale) and late afternoon/evening (PREMB-R PM subscale) functional impairment in children wit
Publikováno v:
Journal of affective disorders. 319
Publikováno v:
Child and adolescent psychiatric clinics of North America. 31(3)
Clinical practice guidelines (CPGs) are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. CPGs have evolved during the last 2 decades from general conse
Autor:
Steven R. Pliszka
Publikováno v:
Focus (American Psychiatric Publishing). 14(1)
Up to 10% of school-age children have attention-deficit hyperactivity disorder (ADHD), which often persists into adulthood. ADHD can be associated with significant comorbidity of disruptive, mood, and anxiety disorders. Although many children with AD
Autor:
Steven R. Pliszka
Publikováno v:
Journal of Attention Disorders. 23:203-205
Autor:
Rose Marie Larios, Michel Tabet, Blake Novy, Donna J. Roybal, Evan Gregg, Ewelina Migut, Crystal Franklin, Peter T. Fox, Amy Garrett, Steven R. Pliszka
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:S171
Autor:
Steven R. Pliszka
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:S124
Publikováno v:
CNS Drugs
Background Psychostimulants are considered first-line pharmacotherapy for youth with attention-deficit/hyperactivity disorder (ADHD), but questions remain regarding the comparative efficacy of amphetamine- and methylphenidate-based agents. Objective
Autor:
Steven R. Pliszka, Ann Catherine Childress, Andrew J. Cutler, Andrea Marraffino, Norberto J. DeSousa, Floyd R. Sallee, Bev Incledon
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 59:S155-S156